Evolent Health, Inc. expected to post a loss of 2 cents a share - Earnings Preview

Evolent Health

04/08/2026 15:39

Evolent Health, Inc. EVH.N, EVH is expected to  show a rise in quarterly revenue when it reports  results on August 6 for the period ending June 30 2026
The Arlington Virginia-based  company is expected to report a 34.6% increase in revenue to $597.997 million from $444.33 million a year ago, according to the mean estimate from 15 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Evolent Health, Inc. is for a loss of 2 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Evolent Health, Inc. is $6.00, about 91.1% above its last closing price of $3.14
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.06
-0.05
-0.02
Beat
61
Dec. 31 2026
0.05
0.06
0.08
Beat
39
Sep. 30 2025
0.10
0.10
0.05
Missed
-52.2​
Jun. 30 2025
0.08
0.08
-0.10
Missed
-227.7
​​Mar. 31 2025
0.10
0.10
0.06
Missed
-37.1
Dec. 31 2024
0.02
0.01
-0.02
Missed
-335.3​
Sep. 30 2024
0.36
0.34
0.04
Missed
-88.3
Jun. 30 2024
0.28
0.25
0.30
Beat
18.6
This summary was machine generated August 4 at 14:39 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)